Larimar Therapeutics (LRMR) PT Lowered to $5 at Baird
Tweet
Share
E-mailGet Alerts LRMR Hot Sheet
Price: $3.81 -0.52%
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 25 | Down: 23 | New: 33
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 25 | Down: 23 | New: 33
Join SI Premium – FREE
Baird analyst Joel Beatty lowered the price target on Larimar Therapeutics (NASDAQ: LRMR) to $5.00 (from $7.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Quest Diagnostics (DGX) PT Raised to $245 at UBS
- Shopify (SHOP) PT Raised to $180 at Piper Sandler
- Roivant Sciences (ROIV) PT Raised to $52 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
